-
Holding Off on Treatment
Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.
by Jon Kelvey
-
Young Colorectal Cancer Patients Are Often Misdiagnosed
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
Considering the Term “Cancer Survivor”
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
What Do Clinical Trial Endpoints Really Measure?
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
-
Shingles Risk Increased for Cancer Patients
A new vaccine is safe for cancer patients but hard to find.
by Nancy Averett
-
Treating Breast Cancer in Men
Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.
by Marilyn Fenichel
-
Combining Treatment With Hospice Services
Organizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.
by Cheryl Platzman Weinstock
-
2018: This Year in Cancer News
The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.
by Cancer Today Staff
-
The Education of a Patient Advocate
Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles